NYSE:THC (USA) Also trade in: Germany

Tenet Healthcare Corp

$ 20.99 -0.2 (-0.94%)
Volume: 483,321 Avg Vol (1m): 1,460,192
Market Cap $: 2.16 Bil Enterprise Value $: 17.69 Bil
P/E (TTM): 0.00 P/B: 0.00
Earnings Power Value 61.17
Net Current Asset Value -182.03
Tangible Book -88.45
Projected FCF 6.81
Median P/S Value 47.43
Graham Number 0
Peter Lynch Value -1.51
DCF (FCF Based) 28.87
DCF (Earnings Based) -1.82
1Y (-%)

Financial Strength : 3/10

GuruFocus Financial Strength Rank measures how strong a company's financial situation is . It is based on these factors
1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.
A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.
Current vs industry vs history
Cash-to-Debt 0.02
Cash-To-Debt ranked lower than
88.69% of 274 companies
in the Medical Care industry.
Industry Max: 10000, Med: 0.28, Min: 0.01
THC: 0.02
Ranked among companies with meaningful Cash-To-Debt only.
Cash-To-Debt range over the past 10 years
Min: 0, Med: 0.04, Max: 0.39
Current: 0.02
0
0.39
Equity-to-Asset -0.01
Equity-to-Asset ranked lower than
94.05% of 269 companies
in the Medical Care industry.
Industry Max: 0.97, Med: 0.48, Min: -15.93
THC: -0.01
Ranked among companies with meaningful Equity-to-Asset only.
Equity-to-Asset range over the past 10 years
Min: -0.01, Med: 0.27, Max: 0.45
Current: -0.01
-0.01
0.45
Debt-to-Equity -111.73
Debt-to-Equity ranked lower than
100.00% of 202 companies
in the Medical Care industry.
Industry Max: 25.64, Med: 0.64, Min: 0.01
THC: -111.73
Ranked among companies with meaningful Debt-to-Equity only.
Debt-to-Equity range over the past 10 years
Min: -229.06, Med: 1.62, Max: 620.04
Current: -111.73
-229.06
620.04
Debt-to-EBITDA 6.63
Debt-to-EBITDA ranked lower than
86.57% of 201 companies
in the Medical Care industry.
Industry Max: 66.84, Med: 2.81, Min: 0.01
THC: 6.63
Ranked among companies with meaningful Debt-to-EBITDA only.
Debt-to-EBITDA range over the past 10 years
Min: 4.02, Med: 6.35, Max: 12.6
Current: 6.63
4.02
12.6
Interest Coverage 1.55
Interest Coverage ranked lower than
92.51% of 227 companies
in the Medical Care industry.
Industry Max: 48765, Med: 6.85, Min: 0.01
THC: 1.55
Ranked among companies with meaningful Interest Coverage only.
Interest Coverage range over the past 10 years
Min: 1.34, Med: 1.55, Max: 1.94
Current: 1.55
1.34
1.94
Piotroski F-Score 5
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 0.95
DISTRESS
GREY
SAFE
WACC vs ROIC %
ROIC 7.53%
WACC 13.4%

Profitability & Growth : 7/10

GuruFocus Profitability Rank ranks how profitable a company is and how likely the company's business will stay that way.
Current vs industry vs history
Operating Margin % 8.55
Operating Margin ranked lower than
56.62% of 272 companies
in the Medical Care industry.
Industry Max: 66.83, Med: 6.83, Min: -3742
THC: 8.55
Ranked among companies with meaningful Operating Margin only.
Operating Margin range over the past 10 years
Min: 6.57, Med: 7.48, Max: 8.83
Current: 8.55
6.57
8.83
Net Margin % -0.04
Net Margin ranked lower than
79.41% of 272 companies
in the Medical Care industry.
Industry Max: 202.55, Med: 3.88, Min: -4897.7
THC: -0.04
Ranked among companies with meaningful Net Margin only.
Net Margin range over the past 10 years
Min: -3.67, Med: 0.34, Max: 13.83
Current: -0.04
-3.67
13.83
ROA % -0.03
ROA ranked lower than
80.95% of 273 companies
in the Medical Care industry.
Industry Max: 52.42, Med: 3.48, Min: -3383.78
THC: -0.03
Ranked among companies with meaningful ROA only.
ROA range over the past 10 years
Min: -2.93, Med: 0.28, Max: 13.89
Current: -0.03
-2.93
13.89
ROC (Joel Greenblatt) % 19.21
ROC (Joel Greenblatt) ranked lower than
56.25% of 272 companies
in the Medical Care industry.
Industry Max: 8470.37, Med: 14.91, Min: -33236.56
THC: 19.21
Ranked among companies with meaningful ROC (Joel Greenblatt) only.
ROC (Joel Greenblatt) range over the past 10 years
Min: 4.72, Med: 12.89, Max: 20.97
Current: 19.21
4.72
20.97
3-Year Total Revenue Growth Rate -0.60
3-Year Revenue Growth Rate ranked lower than
55.92% of 211 companies
in the Medical Care industry.
Industry Max: 314.7, Med: 6.5, Min: -100
THC: -2.1
Ranked among companies with meaningful 3-Year Revenue Growth Rate only.
3-Year Revenue Growth Rate range over the past 10 years
Min: -13.7, Med: -0.2, Max: 32.4
Current: -2.1
-13.7
32.4
3-Year Total EBITDA Growth Rate 9.70
3-Year EBITDA Growth Rate ranked lower than
63.59% of 184 companies
in the Medical Care industry.
Industry Max: 236.4, Med: 5.9, Min: -108
THC: 8
Ranked among companies with meaningful 3-Year EBITDA Growth Rate only.
3-Year EBITDA Growth Rate range over the past 10 years
Min: 0, Med: 3.5, Max: 38.5
Current: 8
0
38.5

» THC's 30-Y Financials

Financials (Next Earnings Date: 2019-08-07)

Guru Trades Click for details

» Details

Insider Trades

SEC Filings

Gurus Latest Trades with NYSE:THC

» Interactive Chart

Peter Lynch Chart

Business Description

Industry Health Care Providers » Medical Care    NAICS : 622110    SIC : 8062
Compare NYSE:MD SAU:4002 NYSE:AMN NSE:APOLLOHOSP JSE:LHC XSGO:BANMEDICA NAS:LPNT NYSE:SEM XTER:RHK ISX:MIKA JSE:NTC NAS:ACHC TSE:7716 ASX:HSO LSE:MDC BKK:SVH-F NYSE:USPH OTCPK:BLSTF BOM:532843 SGX:BSL
Traded in other countries THC1.Germany
Address 1445 Ross Avenue, Suite 1400, Dallas, TX, USA, 75202
Based in Dallas, Tenet Healthcare is one of the largest acute-care firms in the U.S., accounting for roughly 2% of the country's hospital admissions. It operates over 79 acute-care hospitals with more than 20,000 beds, as well as over 475 ambulatory surgery centers, diagnostic imaging centers, and urgent care centers, and a revenue cycle subsidiary called Conifer. Tenet has facilities in numerous states, with most of its total operations in California, Florida, and Texas. Outpatient services make up about 36% of Tenet's patient revenue.

Ratios

Current vs industry vs history
Forward PE Ratio 9.59
Forward P/E ranked lower than
71.19% of 59 companies
in the Medical Care industry.
Industry Max: 107.53, Med: 20.66, Min: 8.31
THC: 9.59
Ranked among companies with meaningful Forward P/E only.
N/A
PS Ratio 0.11
PS Ratio ranked higher than
97.33% of 262 companies
in the Medical Care industry.
Industry Max: 79.41, Med: 1.7, Min: 0.03
THC: 0.11
Ranked among companies with meaningful PS Ratio only.
PS Ratio range over the past 10 years
Min: 0.05, Med: 0.27, Max: 0.57
Current: 0.11
0.05
0.57
Price-to-Free-Cash-Flow 7.79
Price-to-Free-Cash-Flow ranked higher than
95.56% of 135 companies
in the Medical Care industry.
Industry Max: 777.22, Med: 23.01, Min: 1.25
THC: 7.79
Ranked among companies with meaningful Price-to-Free-Cash-Flow only.
Price-to-Free-Cash-Flow range over the past 10 years
Min: 2.73, Med: 15.89, Max: 811.2
Current: 7.79
2.73
811.2
Price-to-Operating-Cash-Flow 2.29
Price-to-Operating-Cash-Flow ranked higher than
96.77% of 186 companies
in the Medical Care industry.
Industry Max: 1706.9, Med: 14.67, Min: 0.7
THC: 2.29
Ranked among companies with meaningful Price-to-Operating-Cash-Flow only.
Price-to-Operating-Cash-Flow range over the past 10 years
Min: 1.12, Med: 5.24, Max: 15.64
Current: 2.29
1.12
15.64
EV-to-EBIT 12.16
EV-to-EBIT ranked higher than
60.75% of 214 companies
in the Medical Care industry.
Industry Max: 3101.61, Med: 21.68, Min: 1.06
THC: 12.16
Ranked among companies with meaningful EV-to-EBIT only.
EV-to-EBIT range over the past 10 years
Min: 6.4, Med: 14.1, Max: 49.1
Current: 12.16
6.4
49.1
EV-to-EBITDA 7.85
EV-to-EBITDA ranked higher than
80.70% of 228 companies
in the Medical Care industry.
Industry Max: 1827.89, Med: 15.23, Min: 0.9
THC: 7.85
Ranked among companies with meaningful EV-to-EBITDA only.
EV-to-EBITDA range over the past 10 years
Min: 4.1, Med: 8.3, Max: 18
Current: 7.85
4.1
18
EV-to-Revenue 0.97
EV-to-Revenue ranked higher than
81.92% of 271 companies
in the Medical Care industry.
Industry Max: 158.19, Med: 2.17, Min: 0.06
THC: 0.97
Ranked among companies with meaningful EV-to-Revenue only.
EV-to-Revenue range over the past 10 years
Min: 0.5, Med: 0.9, Max: 1.4
Current: 0.97
0.5
1.4
Shiller PE Ratio 945.46
Shiller PE Ratio ranked lower than
93.55% of 62 companies
in the Medical Care industry.
Industry Max: 1305.92, Med: 31.76, Min: 8.18
THC: 945.46
Ranked among companies with meaningful Shiller PE Ratio only.
Shiller PE Ratio range over the past 10 years
Min: 20.33, Med: 92.83, Max: 1559.5
Current: 945.46
20.33
1559.5
Current Ratio 1.23
Current Ratio ranked lower than
53.08% of 260 companies
in the Medical Care industry.
Industry Max: 13.59, Med: 1.34, Min: 0.04
THC: 1.23
Ranked among companies with meaningful Current Ratio only.
Current Ratio range over the past 10 years
Min: 0.88, Med: 1.45, Max: 2.38
Current: 1.23
0.88
2.38
Quick Ratio 1.15
Quick Ratio ranked lower than
51.15% of 260 companies
in the Medical Care industry.
Industry Max: 13.59, Med: 1.24, Min: 0.04
THC: 1.15
Ranked among companies with meaningful Quick Ratio only.
Quick Ratio range over the past 10 years
Min: 0.85, Med: 1.36, Max: 2.29
Current: 1.15
0.85
2.29
Days Inventory 8.95
Days Inventory ranked higher than
72.82% of 206 companies
in the Medical Care industry.
Industry Max: 464.03, Med: 17.07, Min: 0.09
THC: 8.95
Ranked among companies with meaningful Days Inventory only.
Days Inventory range over the past 10 years
Min: 8.37, Med: 8.95, Max: 10.56
Current: 8.95
8.37
10.56
Days Sales Outstanding 55.16
Days Sales Outstanding ranked lower than
62.56% of 227 companies
in the Medical Care industry.
Industry Max: 524.5, Med: 39.87, Min: 0.25
THC: 55.16
Ranked among companies with meaningful Days Sales Outstanding only.
Days Sales Outstanding range over the past 10 years
Min: 46.89, Med: 52.91, Max: 62.22
Current: 55.16
46.89
62.22
Days Payable 32.57
Days Payable ranked lower than
53.41% of 176 companies
in the Medical Care industry.
Industry Max: 1871.61, Med: 40.58, Min: 1
THC: 32.57
Ranked among companies with meaningful Days Payable only.
Days Payable range over the past 10 years
Min: 32.42, Med: 40.88, Max: 51.43
Current: 32.57
32.42
51.43

Dividend & Buy Back

Current vs industry vs history
3-Year Share Buyback Rate -1.80
3-Year Share Buyback Rate ranked higher than
64.78% of 159 companies
in the Medical Care industry.
Industry Max: 100, Med: -2.5, Min: -549.3
THC: -1.8
Ranked among companies with meaningful 3-Year Share Buyback Rate only.
3-Year Share Buyback Rate range over the past 10 years
Min: -22.2, Med: -0.8, Max: 7.3
Current: -1.8
-22.2
7.3

Valuation & Return

Current vs industry vs history
Price-to-Projected-FCF 3.08
Price-to-Intrinsic-Value-Projected-FCF ranked lower than
100.00% of 101 companies
in the Medical Care industry.
Industry Max: 20.14, Med: 1.98, Min: 0.07
THC: 3.08
Ranked among companies with meaningful Price-to-Intrinsic-Value-Projected-FCF only.
Price-to-Intrinsic-Value-Projected-FCF range over the past 10 years
Min: 0.64, Med: 1.88, Max: 61.81
Current: 3.08
0.64
61.81
Price-to-Median-PS-Value 0.44
Price-to-Median-PS-Value ranked higher than
95.19% of 208 companies
in the Medical Care industry.
Industry Max: 12, Med: 1.03, Min: 0.01
THC: 0.44
Ranked among companies with meaningful Price-to-Median-PS-Value only.
Price-to-Median-PS-Value range over the past 10 years
Min: 0.24, Med: 1.92, Max: 6.65
Current: 0.44
0.24
6.65
Earnings Yield (Joel Greenblatt) % 8.20
Earnings Yield (Greenblatt) ranked higher than
69.23% of 273 companies
in the Medical Care industry.
Industry Max: 94.34, Med: 3.61, Min: -217.39
THC: 8.2
Ranked among companies with meaningful Earnings Yield (Greenblatt) only.
Earnings Yield (Greenblatt) range over the past 10 years
Min: 2, Med: 7.1, Max: 15.7
Current: 8.2
2
15.7
Forward Rate of Return (Yacktman) % 12.14
Forward Rate of Return ranked higher than
86.47% of 133 companies
in the Medical Care industry.
Industry Max: 868.48, Med: 9.1, Min: -81.77
THC: 12.14
Ranked among companies with meaningful Forward Rate of Return only.
Forward Rate of Return range over the past 10 years
Min: -103.1, Med: 5.45, Max: 22.6
Current: 12.14
-103.1
22.6

More Statistics

Revenue (TTM) (Mil) $ 18,159
EPS (TTM) $ -0.07
Beta 2.11
Volatility % 66.43
52-Week Range $ 16.61 - 39.74
Shares Outstanding (Mil) 103.13

Analyst Estimate

Piotroski F-Score Details

Piotroski F-Score 5
Positive ROA N
Positive CFROA Y
Higher ROA yoy Y
CFROA > ROA Y
Lower Leverage yoy N
Higher Current Ratio yoy N
Less Shares Outstanding yoy N
Higher Gross Margin yoy Y
Higher Asset Turnover yoy Y